Preparation, characterization and evaluation of bufalin liposomes coated with citrus pectin

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 444, Issue , 2014, Pages 54-62

  Li, Ying ^a   Zhao, Hang ^a   Duan, Lin Rui ^a   Li, Hua ^a   Yang, Qian ^a   Tu, Hong Hai ^b   Cao, Wei ^a   Wang, Si Wang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Institute for Drug and Instrument Control   (China)

Author keywords

Bufalin; Citrus pectin; Colon cancer; Liposomes

Indexed keywords

DISEASES; DRUG DELIVERY;

BUFALIN; CITRUS PECTIN; COLON CANCER; DRUG CARRIER SYSTEMS; ENTRAPMENT EFFICIENCY; LIPOSOMAL DRUG DELIVERY SYSTEMS; MUCOADHESIVE PROPERTIES; PREPARATION CONDITIONS;

LIPOSOMES;

BUFALIN; LIPOSOME; NANOCARRIER; PECTIN;

ADSORPTION; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; COLON CANCER; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STABILITY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HYDRATION; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR WEIGHT; MUCOADHESION; NANOENCAPSULATION; PRIORITY JOURNAL; STATIC ELECTRICITY; ZETA POTENTIAL;

EID: 84892140851     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2013.12.006     Document Type: Article

References (31)

1. Cerny J., Hassan A., Smith C., Piperdi B. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen. Clin. Colorectal Cancer 2009, 8:55-58.
2. Lin J., Yu Y., Shigdar S., Fang D.Z., Du J.R., Wei M.Q., Danks A., Liu K., Duan W. Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer. PLoS ONE 2012, 7:e49277.
3. Sala-Vila A., Calder P.C. Update on the relationship of fish intake with prostate, breast, and colorectal cancers. Crit. Rev. Food Sci. Nutr. 2011, 51:855-871.
4. Xie C.M., Chan W.Y., Yu S., Zhao J., Cheng C.H. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radic. Biol. Med. 2011, 51:1365-1375.
5. Li F., Wang T., He H.B., Tang X. The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int. J. Pharm. 2008, 349:291-299.
6. Yin P., Wang Y., Qiu Y., Hou L., Liu X., Qin J., Duan Y., Liu P., Qiu M., Li Q. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity. Int. J. Nanomed. 2012, 7:3961-3969.
7. Bick R.J., Poindexter B.J., Sweney R.R., Dasgupta A. Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking. Life Sci. 2002, 72:699-709.
8. P.F. Liu, M.J. Zhu, Y.G. Li, H.Z. Wang, Y.R. Duan, The research on cytotoxicity and cellular uptake of mPEG-PLGA-PLL nanoparticles, the International Conference on Advanced Fibers and Polymer Materials, Shanghai, China, 2009, pp. 1190-1192.
9. Segal N.H., Saltz L.B. Evolving treatment of advanced colon cancer. Annu. Rev. Med. 2009, 60:207-219.
10. Li D.C., Zhong X.K., Zeng Z.P., Jiang J.G., Li L., Zhao M.M., Yang X.Q., Chen J., Zhang B.S., Zhao Q.Z., Xie M.Y., Xiong H., Deng Z.Y., Zhang X.M., Xu S.Y., Gao Y.X. Application of targeted drug delivery system in Chinese medicine. J. Control. Release 2009, 138:103-112.
11. Han H.K., Shin H.J., Ha D.H. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur. J. Pharm. Sci. 2012, 46:500-507.
12. Wang A.Z., Langer R., Farokhzad O.C. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 2012, 63:185-198.
13. Smistad G., Boyum S., Alund S.J., Samuelsen A.B., Hiorth M. The potential of pectin as a stabilizer for liposomal drug delivery systems. Carbohydr. Polym. 2012, 90:1337-1344.
14. Davis M.E., Chen Z.G., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
15. Park K. Nanotechnology: What it can do for drug delivery. J. Control. Release 2007, 120:1-3.
16. Gao L., Cui Y., He Q., Yang Y., Fei J., Li J. Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation. Chem. A Eur. J. 2011, 17:13170-13174.
17. Gao L., Fei J., Zhao J., Li H., Cui Y., Li J. Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy in vitro. ACS Nano 2012, 6:8030-8040.
18. Du C., Zhao J., Fei J., Gao L., Cui W., Yang Y., Li J. Alginate-based microcapsules with a molecule recognition linker and photosensitizer for the combined cancer treatment. Chem. An Asian J. 2013, 8:736-742.
19. He Q., Cui Y., Li J. Molecular assembly and application of biomimetic microcapsules. Chem. Soc. Rev. 2009, 38:2292-2303.
20. Nguyen S., Alund S.J., Hiorth M., Kjoniksen A.L., Smistad G. Studies on pectin coating of liposomes for drug delivery. Colloids Surf. B Biointerfaces 2011, 88:664-673.
21. Alund S.J., Smistad G., Hiorth H. A multivariate analysis investigating different factors important for the interaction between liposomes and pectin. Colloids Surf. A Physicochem. Eng. Aspects 2013, 420:1-9.
22. Klemetsrud T., Jonassen H., Hiorth M., Kjoniksen A.L., Smistad G. Studies on pectin-coated liposomes and their interaction with mucin. Colloids Surf. B Biointerfaces 2013, 103:158-165.
23. Jung J., Arnold R.D., Wicker L. Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier. Colloids Surf. B Biointerfaces 2013, 104:116-121.
24. Olano-Martin E., Rimbach G.H., Gibson G.R., Rastall R.A. Pectin and pectic-oligosaccharides induce apoptosis in in vitro human colonic adenocarcinoma cells. Anticancer Res. 2003, 23:341-346.
25. Ohkami H., Tazawa K., Yamashita I., Shimizu T., Murai K., Kobashi K., Fujimaki M. Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis. Jpn. J. Cancer Res. 1995, 86:523-529.
26. Tazawa K., Okami H., Yamashita I., Ohnishi Y., Kobashi K., Fujimaki M. Anticarcinogenic action of apple pectin on fecal enzyme activities and mucosal or portal prostaglandin E2 levels in experimental rat colon carcinogenesis. J. Exp. Clin. Cancer Res. 1997, 16:33-38.
27. Qiang F., Shin H.J., Lee B.J., Han H.K. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int. J. Pharm. 2012, 430:161-166.
28. Yang S., Chen J., Zhao D., Han D., Chen X. Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency. Int. J. Pharm. 2012, 434:155-160.
29. Song J., Shi F., Zhang Z., Zhu F., Xue J., Tan X., Zhang L., Jia X. Formulation and evaluation of celastrol-loaded liposomes. Molecules 2011, 16:7880-7892.
30. Thirawong N., Thongborisute J., Takeuchi H., Sriamornsak P. Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J. Control. Release 2008, 125:236-245.
31. Tian Q., Wang X.H., Wang W., Zhang C.N., Wang P., Yuan Z. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid. Nanomedicine 2012, 8:870-879.